Delivery Order 75F40120D00032-75F40123F19007
Award Date
12/23/22
Potential Completion Date
11/30/24
Potential Value
$183K
Federal Agency
Food and Drug Administration
Awardee
We Pharma, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20903, USA
Solicitation Procedures
Two Step
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
We Pharma, Inc. doing business as WEP Clinical has been awarded a firm fixed price delivery order valued at $2,000,000 by the Department of Health and Human Services' Food and Drug Administration (HHS FDA) to provide pharmaceutical products and services in support of FDA operations. This task order was issued against We Pharma's existing indefinite delivery contract with HHS FDA, valued at $6 million over five years, to supply drug products and emergency delivery services for FDA research and...
This firm-fixed-price purchase order was awarded by the Food and Drug Administration (FDA), a civilian agency under the Department of Health and Human Services, to We Pharma, Inc., a self-certified small disadvantaged business. The $214,914.90 contract is for the provision of "PHYSICOCHEMICAL PRODUCTS" and has a total small business set-aside. The award supports the FDA's regulatory science program and provides pharmaceutical drug products for the agency's research, compliance, and...
We Pharma, Inc. doing business as WEP Clinical has been awarded a firm fixed price delivery order valued at one hundred thousand dollars from the Department of Health and Human Services' Food and Drug Administration (HHS FDA) to provide currently marketed drug products for FDA research studies. This order was issued against the company's existing five-year, nine and a half million dollar contract awarded in 2020 by HHS FDA to supply drug products for internal research in support of the...
<p>The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $409,719 firm fixed price delivery order contract to We Pharma, Inc., doing business as WEP Clinical, for Pharmaceutical Drug Product Orders. The contract has a period of performance starting on July 31, 2023 through August 6, 2024 and will be performed in Silver Spring, Maryland.</p>
This firm-fixed-price purchase order contract was awarded by the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services, to We Pharma, Inc., doing business as WEP Clinical. The contract, valued at $197,000.00, is for the procurement of pharmaceutical drug products to support the FDA's Center for Drug Evaluation and Research (CDER) research and regulatory activities. WEP Clinical, a self-certified small disadvantaged business, specializes...
This delivery order against the Department of Health and Human Services Food and Drug Administration is for the purpose of obtaining currently marketed drug products for FDA research studies. Awarded on September 30, 2020 to We Pharma, Inc. located in Morrisville, North Carolina, this firm fixed price contract has a potential value of $246,754.22 and period of performance through September 29, 2021. No set-aside designation was applied. We Pharma Inc. will provide the requested drug products...
The Department of Health and Human Services Food and Drug Administration awarded a $145,636.17 firm fixed price delivery order to We Pharma, Inc. of Silver Spring, Maryland for pharmaceutical products to support domestic manufacturing. No set-aside provisions were applied to this contract. We Pharma will provide the FDA's Office of Pharmaceutical Quality with domestic pharmaceutical manufacturing supplies through September 30th, 2022 at their Silver Spring location. As the regulatory body...
The Department of Health and Human Services Food and Drug Administration awarded a $250,000 firm fixed price delivery order contract to We Pharma, Inc. of Morrisville, North Carolina. The purpose of this requirement is to obtain currently marketed drug products for FDA research studies. Performance will take place in Morrisville, North Carolina through September 2021. No set-aside designation was applied to this award made under an unidentified contracting vehicle. The prime contractor will...
The Department of Health and Human Services Food and Drug Administration awarded a firm fixed-price purchase order to The Pharma Letter LIMITED, a for-profit organization, for a $113,008.00 pharmaceutical subscription for 25 users. The contract has a performance period ending May 20, 2025, with an award date of May 20, 2020. The subscription provides the FDA's Office of Global Policy and Strategy (OGPS) staff with access to global news, expert commentary, and analysis on pharmaceutical, generic,...
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $308,625.00 purchase order contract to NMD Group, LLC, a woman-owned small business, to support the FDA's planning for real-world data and real-world evidence related to COVID-19. The contract has a completion date of September 7, 2021 and is structured as a labor hours contract. This contract award appears to be part of the FDA's efforts to accelerate planning and utilization of real-world data and...